Financial incentives for hypertension control in China (FIHCC study)
- Conditions
- HypertensionCirculatory System
- Registration Number
- ISRCTN13467677
- Lead Sponsor
- Shengjing Hospital of China Medical University
- Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35862120/ (added 22/07/2022) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32014046/ (added 10/06/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 207
1. Aged 35 - 75 years
2. Uncontrolled hypertensive patients (SBP/DBP = 140/90mmHg)
3. Have WeChat and use skillfully
4. Local residents, who live in local places for more than 12 months
5. Voluntarily joined and signed informed consents
1. Pregnant women or women who are planning to become pregnant in the next year
2. Plans to move from the neighborhood in the next year
3. Malignant tumors or severe liver, kidney dysfunction
4. Can not be proficient in using WeChat
5. Secondary hypertension patients
6. Disagree to participate in the study or cannot give the informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure at the baseline and after 1, 3, 6, and 12 months
- Secondary Outcome Measures
Name Time Method 1. Diatolic blood pressure measured using blood pressure monitors at the baseline, and after 1, 3, 6 and 12 months<br>2. The proportion of hypertension control (BP <140/90 mmHg) at 1, 3, 6, and 12 months<br>3. Medication adherence at the baseline, and after 1, 3, 6, and 12 months<br>4. Body mass index assessed by dividing weight in kg by height in metres at the baseline, and after 1, 3, 6, and 12 months<br>5. Physical activity at the baseline, and after 1, 3, 6, and 12 months<br>6. Counseling frequency at the baseline, and after 1, 3, 6, and 12 months<br>7. Counseling content at the baseline, and after 1, 3, 6, and 12 months<br>8. Number of steps in WeChat at the baseline, and after 1, 3, 6, and 12 months<br>9. Pulmonary function at the baseline and after 12 months<br>10. Pulse wave velocity at the baseline and after 12 months<br>11. Ankle brachial index at the baseline and after 12 months<br>12. Cost-effectiveness